Neuroprotection in early stages of Alzheimer’s disease is promoted by transthyretin angiogenic properties

BACKGROUND: While still controversial, it has been demonstrated that vascular defects can precede the onset of other AD hallmarks features, making it an important therapeutic target. Given that the protein transthyretin (TTR) has been established as neuroprotective in AD, here we investigated the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gião, Tiago, Saavedra, Joana, Vieira, José Ricardo, Pinto, Marta Teixeira, Arsequell, Gemma, Cardoso, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385857/
https://www.ncbi.nlm.nih.gov/pubmed/34429155
http://dx.doi.org/10.1186/s13195-021-00883-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385857/
https://www.ncbi.nlm.nih.gov/pubmed/34429155
http://dx.doi.org/10.1186/s13195-021-00883-8

Ejemplares similares